Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.
NVO Key Statistics
NVO News
Novo Nordisk stock has had a difficult three year stretch, yet current valuation checks suggest the market may now be pricing it more cautiously than its fundam...
...
Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study, officially titled “A Placebo-controlled Comparability Study to Compare Two P...
More NVO News
Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodyna...
Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study titled “Investigation of Pharmacokinetics of Two Different Presentations of C...
Amgen’s AMGN key pipeline candidate MariTide is a closely watched drug in the obesity market. The drug can give Amgen exposure to one of the industry's fastest-...
Quantum Foundry Copenhagen and the Novo Nordisk (NVO) Foundation announce plans to establish a new 5,300 m^2 quantum chip fabrication facility in Copenhagen. Th...
Shares of Novo Nordisk (NVO) climbed by 4% to about $47 per share on Wednesday morning even after Deutsche Bank (DB) reaffirmed its Sell rating on the Danish ph...
Novo Nordisk ( (NVO) ) just unveiled an update. Novo Nordisk, a Danish healthcare company specialising in treatments for serious chronic diseases such as diabe...
Key Points Eli Lilly generated nearly two-thirds of its sales from GLP-1 drugs in the second quarter of 2026. Amylyx is one of many competitors seeing success...